Ameloblastic fibrosarcoma is a malignant odontogenic tumor that rarely affects the skull base and surrounding regions. We present a case of a 48-year-old man with histologically confirmed malignant transformation of a benign ameloblastic fibroma 10 years after initial presentation of a localized facial mass. The ameloblastic fibrosarcoma extended from the facial region to the orbit, anterior and middle fossa skull base, the infratemporal fossa, and the cavernous sinus. Progressive proptosis with complete monocular vision loss was the presenting symptom. To our review, our case represents the first report of intradural extension of ameloblastic fibrosarcoma. Using a multidisciplinary skull base approach, resection of all tumors except that in the cavernous sinus was achieved with the resulting defect reconstructed with an anterolateral thigh free flap. The patient had no new neurologic deficits after surgery and underwent adjuvant fractionated radiation therapy. Malignant transformation of ameloblastic fibroma into ameloblastic fibrosarcoma can occur many years after initial presentation. Thus, vigilant long-term follow-up is essential despite the benign nature of the initial pathologic lesion. Use of a multidisciplinary approach is critical in obtaining the optimal outcome in these complex cases.

Download full-text PDF

Source
http://dx.doi.org/10.1097/SCS.0b013e3181c50cf7DOI Listing

Publication Analysis

Top Keywords

ameloblastic fibrosarcoma
20
skull base
16
anterior middle
8
intradural extension
8
extension ameloblastic
8
malignant transformation
8
ameloblastic fibroma
8
years initial
8
initial presentation
8
cavernous sinus
8

Similar Publications

Difference in survival and prognosis between malignant tumors of odontogenic origin.

J Stomatol Oral Maxillofac Surg

November 2024

Sorbonne Université, Paris, France; Department of Maxillo-Facial Surgery, Hôpital Pitié-Salpêtrière, Assistance Publique des Hôpitaux de Paris, Paris, France; Sorbonne université, INSERM UMRS 938, Centre de Recherche de Saint Antoine, Team Cancer Biology and Therapeutics, France.

Introduction: The prognosis of metastatic ameloblastoma (METAM), now defined as a benign tumor, and malignant odontogenic tumors (MOT) is poorly studied in the literature. The aim of this study was to determine the prognosis and factors influencing the survival of these patients.

Material And Methods: Using the SEER database, we retrieved clinical data of patients with malignant tumors of dental origin between 1975 and 2020.

View Article and Find Full Text PDF

Ameloblastic fibroma (AF) and related lesions, namely ameloblastic fibrodentinoma (AFD) and ameloblastic fibro-odontoma (AFO), span a spectrum from true neoplasms to hamartomas. The 2017 World Health Organization classification proposes that AFD and AFO are precursors to odontomas, yet their precise nature remains uncertain. This study examined 19 AF cases, 4 AFD, 15 AFO, 19 odontomas (OD, 14 complex, 5 compound), and 2 ameloblastic fibrosarcomas (AFS), focusing on clinical characteristics, recurrence, and molecular profiles.

View Article and Find Full Text PDF

Ameloblastic fibrosarcoma of the maxilla arising in an old woman, a rare case report and literature review.

BMC Oral Health

June 2024

Department of Oncology, Xiangyang No.1 People's Hospital, Hubei Univeristy of Medicine, Jiefang Road No. 15, XiangYang, Hubei, 441000, China.

Background: Ameloblastic fibrosarcoma (AFS) is a rare malignant odontogenic tumor, commonly occurring in young adults and typically affecting the mandibular region. We report an exceptionally rare and highly atypical case of AFS in an elderly female patient originating from the maxillary bone.

Case Presentation: A 66-year-old woman was admitted with a two-week history of a lump in her left upper molar.

View Article and Find Full Text PDF

A Recurrent Case of Ameloblastic Fibroma in 37-year Old Male.

Kathmandu Univ Med J (KUMJ)

April 2024

Department of Oral and Maxillofacial Pathology, Kantipur Dental College Teaching Hospital, Dhapasi, Kathmandu, Nepal.

Ameloblastic fibroma (AF) is a benign mixed epithelial and mesenchymal odontogenic tumor. This was previously grouped in odontogenic tumor showing odontogenic epithelium with odontogenic ectomesenchyme, with or without hard tissue formation. This report describes a case of ameloblastic fibroma in a 37-yearold male who came with the complain of swelling in the left side of lower jaw since one year.

View Article and Find Full Text PDF

Ameloblastic Fibrosarcoma of the Jaw: Case Report, Genetic Profiling, and Literature Review.

Case Rep Oncol

November 2023

Pathology and Laboratory Medicine Department, Emory School of Medicine, Emory University, Atlanta, GA, USA.

Ameloblastic fibrosarcoma (AFS) is considered a malignant progression resulting from dysplastic changes in an ameloblastic fibroma (AF). Both tumors are extremely rare, with only a few cases reported in the scientific literature. Notably, BRAF mutations have been identified in ameloblastomas, suggesting a connection between ameloblastic morphology and BRAF mutations, as AF is believed to be the precursor neoplasm leading to AFS.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!